SMI closes at 15,037.94 points, up 0.61 percent near record high
Published on 11/10/2026 at 22:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSMI ends near record high
- The SMI closed at 15,037.94 points on Tuesday, November 10, 2026, up 0.61 percent.
- Lower oil prices and hopes of reduced Iran-related escalation supported Swiss equities despite hotter-than-expected US inflation and a weaker Wall Street opening.
- Richemont, Swatch, UBS and Swiss construction stocks led the advance, while Amrize, Sandoz and Galderma declined.
The SMI finished Tuesday, November 10, 2026, at 15,037.94 points, gaining 91.79 points or 0.61 percent. The closing level was reported at 17:30:57 local time and left the Swiss blue-chip index around 55 points below its record high of 15,092.56 points. The finanzen.ch report, citing AWP, provided the dated closing figure and market details.
Oil and Iran hopes support market
Swiss shares remained resilient despite a more difficult US backdrop. October US consumer prices rose 0.4 percent month on month, above the 0.3 percent expected, while core prices increased 0.3 percent. The data reinforced expectations of a December Federal Reserve rate hike and weighed on Wall Street at the start of the US session.
For the SMI, the counterweight came from commodities and geopolitics. Brent crude fell temporarily below 90 US dollars per barrel after signals that further US attacks on Iran were unlikely in the immediate future. Lower energy prices reduced some of the market's near-term inflation pressure, while hopes for less escalation supported risk appetite in Europe.
Richemont leads broad advance
Market breadth was positive: 17 SMI constituents rose and three fell. Richemont gained 2.7 percent, helped by an upbeat outlook from British watch retailer Watches of Switzerland and by easing Middle East concerns. Swatch rose 2.6 percent. Geberit, Sika and Holcim also advanced, while UBS, Swiss Life and Julius Baer supported the financial sector.
The index heavyweights contributed as well. Nestle gained 0.3 percent and Novartis 0.8 percent, while Roche added 0.2 percent. ABB ended 0.6 percent higher after giving back much of its intraday gain amid speculation that a sale of its robotics business to SoftBank could still proceed despite concerns in China. Amrize, Galderma and Sandoz were the main decliners.
Index composition matters for investors
The SMI's defensive structure helped it absorb the day's higher-rate signal. According to SIX, the index comprises 20 of Switzerland's largest and most liquid equities and covers approximately 75 percent of the Swiss equity market's capitalization. That concentration means moves in healthcare, consumer staples and financial heavyweights can materially shape the headline result.
The SMI's gain followed a 1.01 percent rise to 14,946.15 points in the previous completed session, according to Saxo. Investors now face the continuing tension between supportive energy and geopolitical developments and the prospect of higher US rates.
More coverage is available on the SMI topic page.
